A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer

Title
A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer
Authors
Keywords
-
Journal
LUNG CANCER
Volume 74, Issue 3, Pages 481-485
Publisher
Elsevier BV
Online
2011-06-08
DOI
10.1016/j.lungcan.2011.05.005

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search